Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

NCT05595447 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Refractory Hodgkin Lymphoma
Relapsed Hodgkin's Disease, Adult

Interventions

DRUG: Brentuximab Vedotin 50 MG [Adcetris]

Sponsor

Hospital Regional de Alta Especialidad del Bajio

Collaborators

[object Object]